215 related articles for article (PubMed ID: 2577108)
1. Multidrug resistance: clinical findings and implications.
Friedlander ML; Bell DR
Cancer Treat Res; 1989; 42():63-77. PubMed ID: 2577108
[No Abstract] [Full Text] [Related]
2. Laboratory aspects of multidrug resistance.
Fuqua SA; Merkel DE; McGuire WL
Cancer Treat Res; 1989; 42():45-59. PubMed ID: 2577107
[No Abstract] [Full Text] [Related]
3. The clinical relevance of multidrug resistance.
Bellamy WT; Dalton WS; Dorr RT
Cancer Invest; 1990; 8(5):547-62. PubMed ID: 1979932
[No Abstract] [Full Text] [Related]
4. Mechanism of multidrug resistance.
Bradley G; Juranka PF; Ling V
Biochim Biophys Acta; 1988 Aug; 948(1):87-128. PubMed ID: 2899442
[No Abstract] [Full Text] [Related]
5. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
6. Expression of the MDR1 gene in human cancers.
Goldstein LJ; Gottesman MM; Pastan I
Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
[No Abstract] [Full Text] [Related]
7. Multidrug resistance: molecular biology and clinical relevance.
Rothenberg M; Ling V
J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
[No Abstract] [Full Text] [Related]
8. Multidrug resistance: a novel class of membrane-associated transport proteins is identified.
Gros P; Shustik C
Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020
[No Abstract] [Full Text] [Related]
9. Multidrug resistance in leukemia.
Rischin D; Ling V
Cancer Treat Res; 1993; 64():269-93. PubMed ID: 8095795
[No Abstract] [Full Text] [Related]
10. Genetic aspects of multidrug resistance.
Pauly M; Ries F; Dicato M
Med Oncol Tumor Pharmacother; 1992; 9(1):21-4. PubMed ID: 1364127
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance and P-glycoprotein expression in human cancer.
Ma DD; Bell DR
Aust N Z J Med; 1989 Dec; 19(6):736-43. PubMed ID: 2576624
[No Abstract] [Full Text] [Related]
12. Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
Chabner BA; Fojo A
J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356
[No Abstract] [Full Text] [Related]
13. Similarities and differences between the multidrug resistance phenotype of mammalian tumor cells and chloroquine resistance in Plasmodium falciparum.
Karcz S; Cowman AF
Exp Parasitol; 1991 Aug; 73(2):233-40. PubMed ID: 1679719
[No Abstract] [Full Text] [Related]
14. Multidrug resistance in cancer.
Ferry DR; Kerr DJ
BMJ; 1994 Jan; 308(6922):148-9. PubMed ID: 7906169
[No Abstract] [Full Text] [Related]
15. Current status and future directions of research on multidrug resistance. The impact of contemporary biotechnology.
Mickisch GH
Urol Res; 1993 Mar; 21(2):79-81. PubMed ID: 8099243
[No Abstract] [Full Text] [Related]
16. Use of multidrug resistance gene in mammalian expression vectors.
Kane SE; Gottesman MM
Methods Enzymol; 1993; 217():34-47. PubMed ID: 8097271
[No Abstract] [Full Text] [Related]
17. Multidrug resistance genes, p-glycoprotein and the liver.
Arias IM
Hepatology; 1990 Jul; 12(1):159-65. PubMed ID: 1973680
[No Abstract] [Full Text] [Related]
18. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
[No Abstract] [Full Text] [Related]
19. Multidrug resistance due to P-glycoprotein.
Burt RK; Fojo AT; Thorgeirsson SS
Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
[TBL] [Abstract][Full Text] [Related]
20. Cellular resistance to drugs.
Krishan A
Cancer Invest; 1989; 7(2):211-2. PubMed ID: 2571401
[No Abstract] [Full Text] [Related]
[Next] [New Search]